VeriMomDois-je éviter lithium hydroxide pendant la grossesse ? | VeriMom
ECHA/RAC has proposed harmonised classification for lithium hydroxide as reproductive toxicant (Repr. 1A, H360—may damage fertility/unborn child) and lactation (H362); regulatory bodies and risk assessments driving that proposal cite mammalian data and human lithium drug literature showing placental transfer and developmental effects. This supports a confirmed hazard (H360 → h=3) and a demonstrated mechanism (placental transfer / developmental signalling effects from lithium). Topical cosmetic exposure would give low but measurable systemic exposure in normal use (hence e=1). (Sources: ECHA registry and RAC/ANSES material; PubMed reviews on lithium exposure in pregnancy).
ECHA regulatory hazard statements
- •H360
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- lithium hydroxide est-il sûr pendant la grossesse ?
- ECHA/RAC has proposed harmonised classification for lithium hydroxide as reproductive toxicant (Repr. 1A, H360—may damage fertility/unborn child) and lactation (H362); regulatory bodies and risk assessments driving that proposal cite mammalian data and human lithium drug literature showing placental transfer and developmental effects. This supports a confirmed hazard (H360 → h=3) and a demonstrated mechanism (placental transfer / developmental signalling effects from lithium). Topical cosmetic exposure would give low but measurable systemic exposure in normal use (hence e=1). (Sources: ECHA registry and RAC/ANSES material; PubMed reviews on lithium exposure in pregnancy).
- lithium hydroxide est-il sûr pendant l'allaitement ?
- RAC/ANSES proposals include a lactation hazard (H362) for lithium salts; clinical/literature on therapeutic lithium shows transfer into breastmilk and effects on breastfed infants, supporting a confirmed hazard (h=3) and demonstrated mechanism (maternal→milk transfer). Topical cosmetic use is expected to give low but measurable maternal systemic exposure (e=1) unless formulations/uses provide negligible absorption. (Sources: ECHA/ANSES/RAC documentation; PubMed clinical reviews on lithium and breastfeeding).
- lithium hydroxide est-il sûr pour la peau de bébé ?
- Hazard and mechanism remain driven by the same lithium salt evidence (RAC proposal Repr.1A/H360 and lactation H362; systemic lithium crosses placenta and is secreted in milk). Because infant skin (0–3 yr) has higher surface-area-to-weight and a less mature barrier, exposure score is increased by +1 (adult e=1 → infant e=2). There is no infant-specific evidence changing hazard or mechanism, but increased dermal exposure potential supports higher exposure concern for babies. (Sources: ECHA/ANSES/RAC; PubMed literature on lithium transfer and infant effects; CosIng listing and restriction notes).
- Comment VeriMom évalue-t-il lithium hydroxide ?
- VeriMom évalue lithium hydroxide à 20/100 (risque élevé) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à lithium hydroxide pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à lithium hydroxide basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.